Pending EO 12866 Regulatory Review

RIN: 0906-ZA22	Received Date: 02/06/2026
Title: 340B Drug Pricing Program Manufacturer Rebate Models
Agency/Subagency: HHS / HRSA	Stage: Prerule
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No